← Leaderboards
Chris Powala
Nflection Therapeutics, Inc.
$299,697
Attributed
$299,697
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$299,697 · 1
By mechanism
N43$299,697 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Biological Markers”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,644,754
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,375,181
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,483,553
- Leonard Freedmand · Leidos Biomedical Research, Inc.$64,555,721
- Yunda Huang · Fred Hutchinson Cancer Center$54,118,126
- Susan Abushakra · Alzheon, Inc.$50,765,244
Research focus
Biological MarkersBloodBlood CirculationCell SurvivalChemopreventionChemopreventive AgentClinical TrialsDoseDrug VehicleFundingHigh RiskHourImmunohistochemistryImmunosuppressionIncidenceInhibitor/AntagonistKeratinocyteLeadLifeMalignant Squamous Cell NeoplasmMap Kinase GeneMeksMetabolicActinic Keratosis